Strybol Pharma Groep
ActiveSummary
Strybol Pharma Groep has been active since 2011 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €391,741 and a net result of €282,396. Equity fluctuates too strongly from year to year to read a trend from it. Its solvency ranks better than 22% of 12,775 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.6% (low).
Overview
Official details
Source: KBO- Status
- Active since 16-12-2011 Normal situation
- Activity
- Retail sale of pharmaceutical products NACE 47730
- Joint committee
- 313 Paritair Comité voor de apotheken en tarificatiediensten · annual accounts 2025
- Establishment units
- 2.205.489.592 8310 Brugge, since 09-01-2012
- 2.370.360.690 9990 Maldegem, since 01-01-2025and 4 others
- Financial year end
- 31 December
- Peppol
- Reachable since 30-01-2025
Board and ownership
- Strybol InvestDirector · since 01-01-2012 · permanent representative STRYBOL Geert Gabriel Rosina
- Strybol Iben PharmaDirector · since 23-12-2024 · permanent representative STRYBOL Iben Ebert Raven
- Strybol Wout PharmaDirector · since 23-12-2024 · permanent representative STRYBOL Wout Jeroen Marc
- Strybol Iben Pharma45%· score 702025 annual accounts of Strybol Iben Pharma
- Strybol Wout Pharma45%· score 902025 annual accounts of Strybol Wout Pharma
Financial position
- Bankruptcy probabilitywithin 12 months
- 0.6%
- Gross margin
- €1.5m
- ▲ 21×
- Turnover
- ≈ €3.7m
- estimated
- Profit
- €282,396
- ▲ 331%
- Equity
- €391,741
- ▲ 258%
- Total assets
- €3.3m
- ▲ 19×
- Employees on 31-12-2025
- 16
Score breakdownraises riskEquity €391,741 (11.9% of total assets)lowers riskFigures for financial year 2025 (filed on 02-07-2026)Profit of €282,396 (financial year 2025)Founded in 2011Show the evidence
Checked score
About 6 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, small). It does better than 25% of them on solvency, 51% on liquidity, 77% on profitability and 98% on growth.
The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 7 accounts on average 15 days before the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.
Searched, nothing found (2)
Key points
Recent changes
- · Gazette deed Company renamed from DE VELTEM INVEST to Strybol Pharma GroepResignation: STRYBOL Geert Gabriel Rosina (statutory director) · Appointments: STRYBOL INVEST, STRYBOL WOUT PHARMA and STRYBOL IBEN PHARMA · Permanent representatives: STRYBOL Geert Gabriel Rosina, STRYBOL Wout Jeroen Marc and STRYBOL Iben Ebert Raven
- · Gazette deed Incorporation
Comparable companies
These companies have the same main activity as Strybol Pharma Groep: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €2.3m and €4.9m, founded between 2003 and 2015.
| Company | Total assets | Gross margin |
|---|---|---|
| Strybol Pharma Groep Brugge | €3.3m | €1.5m |
| Horus Pharma Belux Anderlecht | €3.3m | €2.0m |
| Pharmacie FOURMY Silly | €2.9m | €1.4m |
| KING KONG Bertem | €4.2m | €1.5m |
| Apotheek Olyslager-Snoeckx Brasschaat | €4.9m | €1.7m |
| KRISTOF BEHEYT Maldegem | €2.3m | €1.4m |
| E-pharma Antwerpen | €3.1m | €0.8m |
Key facts about Strybol Pharma Groep
- What is the company number of Strybol Pharma Groep?
- The company number of Strybol Pharma Groep is 0841.947.033. The VAT number is the same number with BE in front: BE 0841.947.033.
- Where is Strybol Pharma Groep based?
- The registered office is at Maalse Steenweg 319, 8310 Brugge.Company details
- What does Strybol Pharma Groep do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of Strybol Pharma Groep?
- The legal form of Strybol Pharma Groep is Private limited company (BV).
- When was Strybol Pharma Groep founded?
- Strybol Pharma Groep was founded on 16-12-2011.
- Is Strybol Pharma Groep still active?
- Yes, Strybol Pharma Groep is an active enterprise in the KBO register.
- How many employees does Strybol Pharma Groep have?
- Strybol Pharma Groep had an average of 12.3 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does Strybol Pharma Groep fall under?
- In its 2025 annual accounts, Strybol Pharma Groep states joint committee 313 (Paritair Comité voor de apotheken en tarificatiediensten).
- What is the turnover of Strybol Pharma Groep?
- The turnover in financial year 2025 is ≈ €3.7m. This figure is estimated from the gross margin of €1.5m and 30 comparable companies (NACE 477). It probably lies between €2.9m and €5.4m.
- Is Strybol Pharma Groep profitable?
- In financial year 2025, Strybol Pharma Groep made a profit of €282,396.
- Where can I find the annual accounts of Strybol Pharma Groep?
- Strybol Pharma Groep filed 14 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of Strybol Pharma Groep due?
- Strybol Pharma Groep must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.